Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (SHA:600332)

SHA:600332 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	13,289	14,940	18,273	21,309	22,500	22,377
Short-Term Investments	-	8,861	4,446	729.16	2,117	-
Trading Asset Securities	-	4	-	4	56.87	-
Cash & Short-Term Investments	13,289	23,805	22,719	22,042	24,673	22,377
Cash Growth	-36.33%	4.78%	3.07%	-10.66%	10.26%	14.61%
Accounts Receivable	23,173	20,940	19,456	19,598	19,168	17,211
Other Receivables	1,332	1,186	993.65	882.35	920.51	1,276
Receivables	24,506	22,126	20,449	20,480	20,088	18,486
Inventory	12,094	13,138	12,812	11,507	10,672	10,438
Other Current Assets	14,492	2,449	1,782	1,955	1,631	1,510
Total Current Assets	64,381	61,518	57,762	55,984	57,064	52,811
Property, Plant & Equipment	8,496	8,365	7,939	7,516	6,570	5,684
Long-Term Investments	8,870	8,793	10,146	9,452	5,897	2,891
Goodwill	919.94	834.09	830.85	829.47	829.47	829.47
Other Intangible Assets	3,159	3,181	2,829	2,886	2,585	2,582
Long-Term Deferred Tax Assets	1,352	1,286	1,210	1,164	865.34	794.23
Long-Term Deferred Charges	158.18	162.47	558.49	499.77	407.47	143.05
Other Long-Term Assets	486.14	370.9	407.77	256.22	446.54	382.46
Total Assets	87,822	84,511	81,684	78,587	74,665	66,118

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	16,935	17,571	16,320	15,686	14,961	14,733
Accrued Expenses	777.16	3,569	3,673	3,651	3,484	3,478
Short-Term Debt	12,573	9,860	9,123	7,799	9,146	8,428
Current Portion of Long-Term Debt	1,478	2,027	1,332	36.45	498.58	30.03
Current Portion of Leases	-	185.2	190.57	213.38	208.15	215.77
Current Income Taxes Payable	395.12	170.9	118.4	249.26	237	143.41
Current Unearned Revenue	1,229	2,833	5,072	5,430	5,644	2,740
Other Current Liabilities	5,591	2,909	3,088	3,170	3,216	2,485
Total Current Liabilities	38,979	39,125	38,916	36,235	37,395	32,254
Long-Term Debt	5,086	3,174	2,806	3,324	1,639	752.81
Long-Term Leases	404.53	371.47	445.72	578.19	545.84	497.7
Long-Term Unearned Revenue	1,078	1,042	1,002	1,001	930.93	826.86
Pension & Post-Retirement Benefits	-	0.29	0.3	0.29	0.32	0.3
Long-Term Deferred Tax Liabilities	599.48	599.37	625.56	639.53	394.59	331.73
Other Long-Term Liabilities	189.82	116.74	119.31	130.6	121.45	127.87
Total Liabilities	46,337	44,428	43,914	41,909	41,027	34,791

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	1,626	1,626	1,626	1,626	1,626	1,626
Additional Paid-In Capital	10,324	10,324	10,114	10,106	10,106	9,957
Retained Earnings	27,226	25,861	24,179	23,212	20,347	17,497
Comprehensive Income & Other	-42.91	-22.6	-13.84	-24.34	-12.9	-17.48
Total Common Equity	39,132	37,788	35,905	34,919	32,065	29,062
Minority Interest	2,353	2,295	1,865	1,759	1,573	2,264
Shareholders' Equity	41,485	40,083	37,770	36,678	33,638	31,327
Total Liabilities & Equity	87,822	84,511	81,684	78,587	74,665	66,118

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	19,542	15,617	13,897	11,951	12,038	9,924
Net Cash (Debt)	-6,252	8,188	8,823	10,091	12,635	12,453
Net Cash Growth	-	-7.20%	-12.57%	-20.14%	1.47%	24.99%
Net Cash Per Share	-3.85	5.04	5.43	6.21	7.77	7.66
Filing Date Shares Outstanding	1,626	1,626	1,626	1,626	1,626	1,626
Total Common Shares Outstanding	1,626	1,626	1,626	1,626	1,626	1,626
Working Capital	25,402	22,394	18,847	19,748	19,669	20,557
Book Value Per Share	24.07	23.24	22.08	21.48	19.72	17.88
Tangible Book Value	35,053	33,773	32,245	31,203	28,651	25,650
Tangible Book Value Per Share	21.56	20.77	19.83	19.19	17.62	15.78
Buildings	-	6,464	5,213	4,328	3,630	3,317
Machinery	-	5,521	5,106	4,416	4,025	3,582
Construction In Progress	-	1,150	1,846	2,405	2,108	1,564

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 22, 2026

Data Sources Report a data error